国浩律师（北京）事务所 关于 福建万辰生物科技集团股份有限公司 2025 年第八次临时股东会 之 法律意见书 北京市朝阳区东三环北路 38 号泰康金融大厦 9 层 邮编：100026 9 th Floor, Taikang Financial Tower, No. 38 North Road East Third Ring, Chaoyang District, Beijing, 100026, China 电话/Tel: 010-65890699 传真/Fax: 010-65176800 网址/Website: http://www.grandall.com.cn 二零二五年十二月 国浩律师（北京）事务所 法律意见书 国浩律师（北京）事务所 关于福建万辰生物科技集团股份有限公司 法律意见书 国浩京证字【2025】第 0709 号 致：福建万辰生物科技集团股份有限公司 国浩律师（北京）事务所接受福建万辰生物科技集团股份有限公司（以下简 称"公司"或"万辰集团"）的委托，指派律师出席并见证了公司 2025 年 12 月 31 日召开的 2025 年第八次临时股东会（以下简称"本次股东会"），并依据《中华 人民共 ...

证券代码：300972 证券简称：万辰集团 公告编号：2025-132 福建万辰生物科技集团股份有限公司 2025 年第八次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会没有出现否决议案的情形。 2、本次股东会不涉及变更前次股东会决议。 3、本次股东会以现场表决与网络投票相结合的方式召开。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间 （1）现场会议时间： 2025 年 12 月 31 日（星期三）14:30 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的时间为：2025 年 12 月 31 日（星期三）上午 9:15-9:25，9:30-11:30 和下午 13:00-15:00。通过深圳 证券交易所互联网系统投票的具体时间为：2025 年 12 月 31 日（星期三）上午 9:15 至下午 15:00 的任意时间。 2、会议召开地点：福建省漳浦台湾农民创业园公司会议室。 3、会议召开方式：本次股东会采取现场表决与网络投票相结合的方式。 4、会议召集人：公司董事会。 5、会议主持人 ...

经审核，独立董事认为：本次关联交易进展事项不存在损害公司和全体股东 特别是中小股东利益的情形，也不存在影响公司独立性的情形。因此，公司独立 董事一致同意该议案，并同意将该议案提交公司董事会审议。 第四届董事会独立董事第十三次专门会议审核意见 根据《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 及《福建万辰生物科技集团股份有限公司章程》《福建万辰生物科技集团股份有 限公司独立董事工作制度》等法律法规和规章制度的有关规定，福建万辰生物科 技集团股份有限公司（以下简称"公司"）全体独立董事于 2025 年 12 月 30 日 召开第四届董事会独立董事第十三次专门会议，本次会议应参加的独立董事 4 名， 实际参加的独立董事 4 名。全体独立董事本着客观公正的立场，就公司第四届董 事会第四十二次会议相关审议事项发表审核意见如下： （一）关于控股子公司关联交易进展事项的审核意见 福建万辰生物科技集团股份有限公司 独立董事：林丽叶、赵景文、杨帆、郑鲁英 2025 年 12 月 30 日 ...

华兴证券有限公司 关于福建万辰生物科技集团股份有限公司 控股子公司关联交易进展事项的核查意见 华兴证券有限公司（以下简称"华兴证券"或"保荐机构"）作为福建万辰生物 科技集团股份有限公司（以下简称"公司"）向特定对象发行股票并在创业板上市 的持续督导保荐机构，根据《证券发行上市保荐业务管理办法》、《深圳证券交 易所创业板股票上市规则》、《深圳证券交易所上市公司自律监管指引第2号—— 创业板上市公司规范运作》等相关法律、法规和规范性文件的规定，对公司控股 子公司南京金万辰生物科技有限公司（以下简称"南京金万辰"）关联交易进展 事项进行了审慎核查，具体如下： 一、关联交易进展事项概述 福建万辰生物科技集团股份有限公司（原名为"福建万辰生物科技股份有限 公司"）于2022年7月28日召开第三届董事会第十四次会议，审议通过《关于控 股子公司关联交易的议案》，同意公司控股子公司南京金万辰生物科技有限公司 与江苏含羞草农业有限公司（以下简称"江苏含羞草"）签订《农村土地的承包 经营权流转合同》（以下简称"原合同"），南京金万辰受让江苏含羞草拥有的 位于南京市溧水区白马镇王家棚子、五七水库区域总面积约618.77亩土地的承 ...

证券代码：300972 证券简称：万辰集团 公告编号：2025-131 2、本次关联交易进展事项不构成《上市公司重大资产重组管理办法》规定 的重大资产重组。 一、关联交易进展事项概述 福建万辰生物科技集团股份有限公司（原名为"福建万辰生物科技股份有限 公司"，以下统称"公司"）于 2022 年 7 月 28 日召开第三届董事会第十四次会议， 审议通过了《关于控股子公司关联交易的议案》，同意公司控股子公司南京金万 辰生物科技有限公司（以下简称"南京金万辰"）与江苏含羞草农业有限公司（以 下简称"江苏含羞草"）签订《农村土地的承包经营权流转合同》（以下简称"原 合同"），南京金万辰受让江苏含羞草拥有的位于南京市溧水区白马镇王家棚子、 五七水库区域总面积约 618.77 亩土地的承包经营权，期限 30 年，自 2022 年 7 月 29 日起至 2052 年 7 月 28 日止，受让价款 990.23 万元。公司董事林该春女士 为江苏含羞草的法定代表人，同时担任执行董事兼总经理，本次交易构成关联交 易 。 具 体 内 容 详 见 公 司 于 2022 年 7 月 28 日 在 巨 潮 资 讯 网 （https:// ...

证券代码：300972 证券简称：万辰集团 公告编号：2025-130 福建万辰生物科技集团股份有限公司 第四届董事会第四十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二、董事会会议审议情况 全体与会董事经认真审议，形成以下决议： （一）审议通过《关于控股子公司关联交易进展事项的议案》 表决情况：同意 5 票，反对 0 票，弃权 0 票，公司关联董事王丽卿、王泽宁、 林该春、陈文柱回避了该项议案表决。 经与会董事的审议，同意该项议案。 本议案已经公司董事会独立董事专门会议审议通过。 具体内容详见公司披露于巨潮资讯网（www.cninfo.com.cn）的相关公告。 三、备查文件 一、董事会会议召开情况 福建万辰生物科技集团股份有限公司（以下简称"公司"）第四届董事会第 四十二次会议于 2025 年 12 月 30 日在公司会议室以现场结合通讯方式召开，本 次董事会会议通知于 2025 年 12 月 27 日以书面、电子邮件的形式向公司全体董 事发出。会议应出席董事共 9 名，实际出席董事 9 名。本次会议由公司董事长王 丽卿主持，公司高级 ...

Group 1: Core Insights - The transition to the second generation of leadership is crucial for the stability and long-term development of companies in the food and beverage industry, particularly for those founded in the 1990s and early 2000s [1] - By 2025, several food and beverage companies, including Master Kong, Dali Foods, and Youyou Foods, are expected to successfully complete their generational transitions, facing systemic challenges due to changing consumer environments [1] Group 2: Master Kong - Master Kong will officially enter a new phase of leadership with Wei Hongcheng, the third son of founder Wei Yingzhou, taking over as CEO on January 1, 2026, after the retirement of current CEO Chen Yingrang [4] - Under the management of professional managers over the past decade, Master Kong's revenue grew from 51.1 billion to 80.6 billion, and net profit increased from 1.28 billion to 3.73 billion, establishing a modern management system [4] - The company faces challenges as its previous growth model reaches a ceiling, with declining performance in the first half of 2025 indicating the need for transformation [4] Group 3: Dali Foods - Dali Foods, with an annual revenue of 20 billion, will see a management transition from founder Xu Shihui to his daughter Xu Yangyang on November 12, 2025 [7] - The company has experienced a decline in revenue from a peak of 22.29 billion in 2021 to 18.07 billion in 2024, raising questions about Xu Yangyang's ability to revitalize the company's performance [8] - Xu Yangyang has a strong background in the company, having worked in various roles for 17 years, which may aid her in addressing the challenges ahead [8] Group 4: Youyou Foods - Youyou Foods will undergo a unique succession with founder Lu Youzhong stepping down as general manager, passing the role to his nephew Lu You, while his daughter Lu Xin exits the board [11] - This "uncle-nephew co-management" model is a result of a competitive selection process, with Lu You having extensive experience in the company [11] - The company faces significant challenges, including management complexities and reliance on a single strong distribution channel [12] Group 5: Wancheng Group - Wancheng Group will transition to a "aunt-nephew co-management" model, with Wang Lijing taking over as chairperson and Wang Zeneng as general manager following the resignation of founder Wang Jiankun [15] - The transition was accelerated by a crisis involving the founder, leading to a rapid change in leadership dynamics [15] - Wang Zeneng's leadership has already seen aggressive moves, including a significant acquisition and plans for a dual listing [16] Group 6: Huanlejia - Huanlejia's new CEO, Li Zihao, faces immediate challenges with a declining distribution network, having lost 511 distributors in the first half of the year [20] - The company's revenue from distributors has shrunk by 30%, directly impacting its financial performance [20] - Li Zihao is working on rebuilding trust with distributors and implementing strategies for brand and product upgrades [20] Group 7: Other Companies - Companies like Haoxiangni and Liziyuan are also undergoing generational transitions, with new leaders facing similar challenges of product aging and performance decline [21] - The common challenge for these second-generation leaders is to find new growth drivers amid changing consumer demands, akin to a second entrepreneurial venture [21]

Market Overview - The leisure food sector experienced a decline of 0.89% on December 30, with Laiyifen leading the drop [1] - The Shanghai Composite Index closed at 3965.12, down 0.0%, while the Shenzhen Component Index closed at 13604.07, up 0.49% [1] Individual Stock Performance - Key stocks in the leisure food sector showed varied performance, with the following notable movements: - Haoxiangni (002582) increased by 2.17% to close at 10.85, with a trading volume of 202,600 shares and a turnover of 218 million yuan [1] - Hezhima (000716) rose by 0.64% to 6.28, with a trading volume of 273,900 shares and a turnover of 171 million yuan [1] - Laiyifen (603777) fell by 4.25% to 13.51, with a trading volume of 175,400 shares and a turnover of 240 million yuan [2] Capital Flow Analysis - The leisure food sector saw a net outflow of 56.98 million yuan from main funds, while retail investors contributed a net inflow of 31.61 million yuan [2] - Notable capital flows for specific stocks include: - Yuanzu (603886) had a net inflow of 18.19 million yuan from main funds, but a net outflow of 24.81 million yuan from retail investors [3] - Haoxiangni (002582) saw a net inflow of 13.99 million yuan from main funds, with a net outflow of 20.91 million yuan from retail investors [3]

Group 1: Key Insights - The report highlights the strong growth potential of the semiconductor testing industry, particularly for companies like Huafeng Measurement and Control (688200), which is positioned to benefit from the increasing demand for simulation and digital testing machines driven by AI chip requirements [4][5][6] - Guoke Military Industry (688543) is noted for its transition from conventional ammunition to intelligent and information-based ammunition, which is expected to enhance its growth prospects in a high-demand industry [4][5] - Purtai (603659) is recognized as a leading global lithium battery materials platform, with its negative electrode and diaphragm businesses expected to show long-term improvement [4][5] Group 2: Company-Specific Analysis - Wanchen Group (300972) is projected to continue expanding its store count, currently exceeding 18,000, while improving net profit margins through scale effects and supply chain efficiencies [5][6] - Top Group (601689) is actively developing new products in collaboration with major clients, including liquid cooling solutions, which have already secured initial orders worth 1.5 billion [7][8] - Zhuoyue New Energy (688196) is expanding its production capacity in the biofuel sector, with a focus on biodiesel and bio-based materials, supported by favorable policies and a projected internal rate of return of 28.94% for new projects [8][9] Group 3: Industry Trends - The report indicates that the server liquid cooling market is expected to experience significant growth in 2026 and 2027, with companies like Yingweike (002837) poised to capture substantial market share [8][9] - The mechanical equipment sector, particularly companies like Binglun Environment (000811), is expanding its presence in various fields, including nuclear power and industrial heat control, which is expected to provide new growth opportunities [9][10] - The AI industry is driving demand for intelligent control systems, with companies like Zhiwei Intelligent (001339) developing products that cater to this emerging market [10]

Investment Rating - The report maintains a "Buy" rating for all recommended stocks in the consumer sector [11][12][13][14][16][17][21][22]. Core Insights - The report highlights nine advantageous sectors within the consumer industry, including agriculture, retail, social services, automotive, textiles, light industry, food, home appliances, and pharmaceuticals, with key stock recommendations for January 2026 [4][7]. - The report emphasizes the expected growth and profitability of the recommended companies, projecting significant increases in net profits and improvements in cash flow over the next few years [11][12][13][14][16][17][21][22]. Summary by Sector Agriculture - Recommended Stock: Muyuan Foods (牧原股份) - Projected net profits for 2025-2027 are 154.9 billion, 160.2 billion, and 225.5 billion respectively, with corresponding PE ratios of 18, 17, and 12 [11][27]. Retail - Recommended Stock: Shangmei Co., Ltd. (上美股份) - Projected net profits for 2025-2027 are 11.2 million, 14.0 million, and 17.0 million respectively, with corresponding PE ratios of 24, 19, and 16 [12][27]. Social Services - Recommended Stock: Jinjiang Hotels (锦江酒店) - Projected net profits for 2025-2027 are 9.53 million, 10.57 million, and 11.63 million respectively, with corresponding PE ratios of 28, 25, and 23 [13][27]. Automotive - Recommended Stock: Top Group (拓普集团) - Projected net profits for 2025-2027 are 27.8 million, 34.1 million, and 43.3 million respectively, with corresponding PE ratios of 45, 37, and 29 [14][27]. Textiles - Recommended Stock: HLA (海澜之家) - Projected net profits for 2025-2027 are 21.6 million, 23.1 million, and 24.5 million respectively, with corresponding PE ratios of 14, 13, and 12 [16][17][27]. Light Industry - Recommended Stock: Craft Home (匠心家居) - Projected net profits for 2025-2026 are 9.2 million and 12.0 million respectively, with corresponding PE ratios of 22 and 17 [17][27]. Food - Recommended Stock: Wancheng Group (万辰集团) - Projected net profits for 2025-2027 are 12.81 million, 20.46 million, and 26.81 million respectively, with corresponding PE ratios of 30, 19, and 14 [18][27]. Home Appliances - Recommended Stock: Anker Innovations (安克创新) - Projected net profits for 2025-2027 are 26.57 million, 31.98 million, and 38.95 million respectively, with corresponding PE ratios of 22.5, 18.7, and 15.4 [21][27]. Pharmaceuticals - Recommended Stock: Zhaoyan New Drug (昭衍新药) - Projected net profits for 2025-2027 are 0.61 million, 0.85 million, and 0.97 million respectively, with corresponding PE ratios of 31.8, 22.9, and 19.9 [22][27].